Skip to content
WorkTraining.com is now part of the Learn Laws® platform. Learn more.
Learn Laws
Sign In
By Learn Laws®
Published 11/16/2026 Updated 11/16/2026

CDC Solicits Public Input on Target Product Profile for Rapid West Nile Virus Diagnostics


Federal public health authorities have initiated a critical formal step toward closing a persistent diagnostic gap in mosquito-borne illness management. On November 16, 2026, the Centers for Disease Control and Prevention (CDC), operating under the Department of Health and Human Services (HHS), published a notice in the Federal Register requesting public and expert comment on a proposed Target Product Profile (TPP) for a rapid diagnostic test for West Nile virus disease. Designed specifically for use in hospitals and clinical laboratories, the profile establishes a federal benchmark intended to stimulate commercial development of accurate and expedited testing solutions across the United States.

The Strategic Role of Target Product Profiles

In biomedical product development, a Target Product Profile functions as an authoritative planning document. It delineates the intended use, target populations, operational parameters, and both the minimally acceptable and optimal performance specifications of a medical device or diagnostic assay before full-scale commercialization occurs. By drafting and publishing this blueprint, federal health officials seek to eliminate ambiguity for medical technology manufacturers, private laboratories, and academic researchers.

The CDC aims to address an unmet clinical need. Traditional laboratory confirmation of West Nile virus can be complex and time-consuming, frequently relying on specialized testing that may delay immediate patient management decisions. Establishing clear federal benchmarks helps ensure that private industry aligns its research and development investments with real-world clinical requirements.

Statutory Framework and Administrative Oversight

The CDC is pursuing this administrative action under the explicit authority of the Public Health Service Act, specifically relying on Sections 301(a) [42 U.S.C. 241(a)] and 317U [42 U.S.C. 247b-23]. Section 301 authorizes the Secretary of HHS and subordinate agencies to conduct, promote, and coordinate public health research and technical development. Section 317U provides direct authorization for federal measures targeting vector-borne diseases and public health capacity enhancement.

The administrative proceeding is overseen by Dr. Randall Nett, Branch Chief of the Arboviral Diseases Branch within the CDC Division of Vector-Borne Diseases in Fort Collins, Colorado. The official notice was formally issued by Noah Aleshire, Chief Regulatory Officer for the agency.

Core Inquiries for Stakeholders

To ensure the final technical specifications are grounded in operational and economic realities, the CDC has structured its Request for Information around four primary questions addressed to clinicians, clinical laboratory directors, diagnostic developers, and advocacy organizations:

  1. Whether a rapid West Nile virus diagnostic assay would provide genuine utility for improving routine bedside clinical care.
  2. How an expedited test might assist investigators and physicians in evaluating prospective prophylactic measures or therapeutic treatments.
  3. Whether an adequate commercial market exists to support the sustainable manufacturing and distribution of such an assay by private entities.
  4. What specific modifications, parameters, or technical adjustments the federal government should implement prior to finalizing the profile.

By directly probing the existence of a viable commercial marketplace, the agency recognizes that regulatory clearances and federal technical guidance alone cannot succeed without sustainable commercial uptake by healthcare systems.

Public Comment Procedures and Near-Term Timelines

The agency has opened a 60-day public comment window, establishing a deadline of January 15, 2027, for all formal submissions under Docket Number CDC-2026-1684. Written contributions must be submitted via the Federal eRulemaking Portal at regulations.gov or delivered by physical mail to the Arboviral Diseases Branch in Fort Collins. The agency has stated that electronic mail submissions will not be accepted.

Submissions become part of the public administrative record and will appear on the federal portal without alteration. The agency explicitly advised contributors not to include confidential or proprietary business details in their primary submissions, directing that any sensitive business proprietary data must be compartmentalized in designated sections or separate attachments.

Following the close of the comment window, federal officials intend to review submitted data and technical recommendations to refine the TPP. The CDC anticipates publishing the finalized profile in a peer-reviewed scientific journal within six months, at which point the final document will be made accessible through the hosting journal platform to guide public health and private diagnostic manufacturing efforts nationwide.

Learn More

We are not a law firm. The information on this website is for informational purposes only and may not be up to date. Always consult a licensed attorney for personalized legal advice.

Follow Learn Laws®

Follower and subscriber counts may not reflect the most up-to-date information, as these change frequently. Visit each social channel directly for the current follower and subscriber count.

Get HHS and CDC updates by email

Once confirmed, subscribers can select agencies for regulatory alerts.

Save with training bundles

Several courses bought together at one price.

Keep going

Browse all courses
HHS

Non-DOT Reasonable Suspicion Training for Supervisors

Non-DOT Reasonable Suspicion Training is an online course of approximately 2 hours for supervisors in non-regulated workplaces. Focuses on identifying signs of drug/alcohol abuse, understanding the impact, and procedural responsibilities, and covers state-specific issues. Certificate issued after passing the final exam.

2 hours of training All training durations are estimated unless otherwise required by regulations.

$55.00/credit

Non-DOT Urine Specimen Collector Training

Non-DOT Urine Specimen Collector Training is an online course of approximately 5 hours for collectors, employers and third-party collection sites that collect urine specimens outside the DOT program. A certificate is issued after completing the course.

5 hours of training All training durations are estimated unless otherwise required by regulations.

$650.00/credit

HHS

Non-DOT Oral Fluid Collector Training

Non-DOT Oral Fluid Collector Training is an online course of approximately 3 hours for healthcare professionals, collection sites, in-house testing staff and urgent care centers that collect oral fluid for drug tests outside the DOT program. A certificate is issued after completing the course.

3 hours of training All training durations are estimated unless otherwise required by regulations.

$650.00/credit

HHS

DNA Paternity Collector Training

DNA Paternity Collector Training is an online course of approximately 3 hours with no prerequisites. It combines self-paced lessons with live virtual mock collections. A certificate is issued after completing the course.

3 hours of training All training durations are estimated unless otherwise required by regulations.

$750.00/credit

HHS

Non-DOT Hair Specimen Collector Training

Non-DOT Hair Specimen Collector Training is an online course of approximately 3 hours for people who collect hair specimens for private employers, recovery programs and independent collection businesses. A certificate is issued after completing the course.

3 hours of training All training durations are estimated unless otherwise required by regulations.

$600.00/credit

HHS

HIPAA Training for Tribal and Governmental Employees

HIPAA Training for Tribal and Governmental Employees is an online course of approximately 2 hours for tribal health departments, tribal clinics, government agencies and public health staff whose work involves protected health information. A certificate is issued after passing the final exam.

2 hours of training All training durations are estimated unless otherwise required by regulations.

$5.00/credit

Related posts

All Agencies
More

No agencies match.

Explore more